Concepedia

Author

Malathi Anantha

University of British Columbia

Also Known As

Malathi Anantha

40

Publications

1.2K

Citations

20

H-Index

43

Concepts

All Affiliations

University of British ColumbiaBC Cancer AgencyCentre for Drug Research and DevelopmentUppsala UniversityUniversité de Sherbrooke
MA

About

Malathi Anantha is an author at University of British Columbia specializing in pharmacology, medicine, and nanomedicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

552

2

Engineering

6

6

193

3

Biomedical Engineering

6

6

513

4

Biochemistry

5

5

198

5

Natural Sciences

4

4

132

Malathi Anantha

×

25

Publications

1.2K

Citations

20

H-Index

YearCitations

Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding

Nancy Dos Santos, Christine Allen, Anne-Marie Doppen,

Biochimica et Biophysica Acta (BBA) - Biomembranes

2007

332

Copper–topotecan complexation mediates drug accumulation into liposomes

Amandeep Taggar, Jehan Alnajim, Malathi Anantha,

Journal of Controlled Release

2006

66

Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent

Mohamed Wehbe, Malathi Anantha, Minghan Shi,

International Journal of Nanomedicine

2017

63

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine

Maïté Verreault, Dita Strutt, Dana Masin,

BMC Cancer

2011

56

Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development

Mohamed Wehbe, Malathi Anantha, Ian Backstrom,

PLoS ONE

2016

54

Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats

Minghan Shi, Malathi Anantha, Mohamed Wehbe,

Journal of Nanobiotechnology

2018

53

Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin

Jennifer H.E. Baker, Jeffrey Lam, Alaistair H. Kyle,

Clinical Cancer Research

2008

46

Transition Metal-Mediated Liposomal Encapsulation of Irinotecan (CPT-11) Stabilizes the Drug in the Therapeutically Active Lactone Conformation

Euan Ramsay, Jehan Alnajim, Malathi Anantha,

Pharmaceutical Research

2006

46

A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer

Armaan Malhotra, Malathi Anantha, Jeroen Roosendaal,

Journal of Controlled Release

2017

46

Characterization of Cationic Liposome Formulations Designed to Exhibit Extended Plasma Residence Times and Tumor Vasculature Targeting Properties

Emmanuel A. Ho, Euan Ramsay, Mihaela Ginj,

Journal of Pharmaceutical Sciences

2010

42

Page 1